Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Rick Fahrner
Introduction
Rick Fahrner is a notable inventor based in Boxford, MA (US). He has made significant contributions to the field of genetic therapies, particularly in the treatment of lysosomal storage diseases. His work focuses on developing methods and compositions that enhance the delivery of essential enzymes to the central nervous system (CNS).
Latest Patents
Fahrner holds a patent titled "Methods and compositions for CNS delivery of iduronate-2-sulfatase." This invention provides compositions and methods for the effective treatment of lysosomal storage diseases. Specifically, it includes a stable formulation for direct CNS intrathecal administration comprising an iduronate-2-sulfatase (I2S) protein, salt, and a polysorbate surfactant for the treatment of Hunter's Syndrome. This patent highlights his innovative approach to addressing complex medical challenges.
Career Highlights
Rick Fahrner is associated with Shire Human Genetic Therapies, Inc., where he has contributed to advancing genetic therapies. His work has been instrumental in developing treatments that improve the quality of life for patients suffering from rare genetic disorders. His dedication to research and innovation has positioned him as a key figure in the field.
Collaborations
Fahrner has collaborated with notable colleagues, including Gaozhong Zhu and Kris Lowe. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking therapies.
Conclusion
Rick Fahrner's contributions to the field of genetic therapies exemplify the impact of innovative thinking in medicine. His patent for CNS delivery of iduronate-2-sulfatase represents a significant advancement in treating lysosomal storage diseases. Through his work, he continues to inspire future innovations in the healthcare industry.